Nizar Y Saad (Nizar Saad)

Years Active: 2021-2023
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Renatta N Knox, Jocelyn O Eidahl, Lindsay Wallace, Sarah Choudury, Afrooz Rashnonejad, Katelyn Daman, Matthew Guggenbiller, Nizar Y Saad, Michael E Hoover, Liwen Zhang, Owen E Branson, Charles P Emerson, Michael A Freitas, Scott Q Harper
Posttranslational modifications of the DUX4 protein impact toxic function. Annals of neurology (2023)
Renatta N Knox, Jocelyn O Eidahl, Lindsay M Wallace, Sarah G Choudury, Afrooz Rashnonejad, Katelyn Daman, Matthew J Guggenbiller, Nizar Y Saad, Michael E Hoover, Liwen Zhang, Owen E Branson, Charles P Emerson, Michael A Freitas, Scott Q Harper
Post-Translational Modifications of the DUX4 Protein Impact Toxic Function in FSHD Cell Models. Annals of neurology (2023)
Julieta Quintero, Nizar Y Saad, Sabrina M Pagnoni, Daniela K Jacquelin, Laura V Gatica, Scott Q Harper, Alberto Luis Rosa
The DUX4 protein is a co-repressor of the progesterone and glucocorticoid nuclear receptors. FEBS letters 596 (20) (2022)
Nizar Y Saad, Mustafa Al-Kharsan, Sara E Garwick-Coppens, Gholamhossein Amini Chermahini, Madison A Harper, Andrew Palo, Ryan L Boudreau, Scott Q Harper
Human miRNA miR-675 inhibits DUX4 expression and may be exploited as a potential treatment for Facioscapulohumeral muscular dystrophy. Nature communications 12 (1) (2021)

Nizar Y Saad.css-eqlu8i{font-size:small;padding-left:4px;} (Nizar Saad)